Arbutus Biopharma Corp Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-12: Form 10-Q; Exhibit 10.3; Description Forms of Arbutus Biopharma Corporation Restricted Stock Agreement for the 2026 Omnibus Share and Incentive Plan..
- 2026-08-12: Form 10-Q; Exhibit 10.2; Description Forms of Arbutus Biopharma Corporation Option Agreement for the 2026 Omnibus Share and Incentive Plan..
- 2026-07-16: Form 8-K; Exhibit 10.2; Description Letter Agreement, dated July 15, 2026, by and between Arbutus Biopharma, Inc. and Lindsay Androski.
- 2026-07-16: Form 8-K; Exhibit 10.1; Description Termination Agreement, dated July 15, 2026.
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-12 | 10-Q | 10.3 | Forms of Arbutus Biopharma Corporation Restricted Stock Agreement for the 2026 Omnibus Share and Incentive Plan. |
|---|
| 2026-08-12 | 10-Q | 10.2 | Forms of Arbutus Biopharma Corporation Option Agreement for the 2026 Omnibus Share and Incentive Plan. |
|---|
| 2026-07-16 | 8-K | 10.2 | Letter Agreement, dated July 15, 2026, by and between Arbutus Biopharma, Inc. and Lindsay Androski |
|---|
| 2026-07-16 | 8-K | 10.1 | Termination Agreement, dated July 15, 2026 |
|---|
| 2026-05-27 | 8-K | 10.1 | Arbutus Biopharma Corporation 2026 Omnibus Share and Incentive Plan |
|---|
| 2026-03-23 | 10-K | 10.23 | Settlement Agreement, dated March 3, 2026, by and among Arbutus Biopharma Corporation, Genevant Sciences GmbH, Genevant Sciences Ltd., Moderna, Inc. and ModernaTX, Inc. |
|---|
| 2026-03-23 | 10-K | 10.1 | Form of Arbutus Biopharma Corporation Indemnity Agreement. |
|---|